Stroke Average Hospitalization Costs Per Patient in the United States Medicare Population
Key Facts Tuesday, November 22nd, 2011
Stroke Average Hospitalization Costs Per Patient in the United States Medicare Population
Search Publications in Our Online Library
Resources Tuesday, November 22nd, 2011
Use the key word search function below to search a database of more than 50 million citations from the world’s leading scientific, medical and technical journals aggregated from partnerships with libraries and publishers around the globe. For example, if you would like to review journal articles related to the risk of stroke caused by atrial […]
Clot-Busters Improve Outcomes Even With Prior Stroke
News Thursday, November 17th, 2011
By Michael Smith, North American Correspondent, MedPage Today Published: November 16, 2011 Reviewed by Dori F. Zaleznik, MD; Associate Clinical Professor of Medicine, Harvard Medical School, Boston and Dorothy Caputo, MA, RN, BC-ADM, CDE, Nurse Planner Clot-busting drugs improve outcomes after stroke even in people with a history of stroke or diabetes, researchers reported. And outcomes were comparable […]
Multi-Center Clinical Trial: Putting stroke patients in charge improves quality of life
Clinical Trials Thursday, November 17th, 2011
Medicalxpress: Community rehabilitation interventions for stroke patients have not had a great track record of delivering measurable improvements. But new research from New Zealand focused on Maori and Pacific populations shows how a cheap and simple intervention that puts the patient and families in charge can make a difference to their quality of life. The study […]
Clinical Trial Research to Discovery With Actian Vectorwise
Clinical Trials Thursday, November 17th, 2011Big Data Analytics Reduced from Days to Minutes to Help Prevent Future Death and Disability from Many Conditions REDWOOD CITY, Calif.–(BUSINESS WIRE)–Actian Corporation (formerly Ingres Corp) today announced that CTSU (the MRC/Cancer Research UK/BHF Clinical Trial Service Unit & Epidemiological Studies Unit of Oxford University) has selected Vectorwise to extract and analyze data pertaining to the causes, prevention and treatment […]
Genotyped Guided Dosing of Warfarin Clinical Treatment Studies
Therapies Friday, November 11th, 2011
The Genotype Guided Dosing of Warfarin Clinical Trial, sponsored by the National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), is soliciting applications from suitable clinical research centers. The University of Pennsylvania serves as the Clinical Trial Coordinating Center (CTCC) for this study. Clinical sites will participate as a subcontract to the […]
Warfarin Therapy: Evolving Strategies in Anticoagulation
Therapies Friday, November 11th, 2011JON D. HORTON, PHARM.D., and BRUCE M. BUSHWICK, M.D. York Hospital York, Pennsylvania Warfarin is the oral anticoagulant most frequently used to control and prevent thromboembolic disorders. Prescribing the dose that both avoids hemorrhagic complications and achieves sufficient suppression of thrombosis requires a thorough understanding of the drug’s unique pharmacology. Warfarin has a complex dose-response […]
Franciscan Health System Joins WARFARIN Study
Therapies Friday, November 11th, 2011Five More Sites to Begin Enrollment in Coming Weeks – Iverson Genetic Diagnostics said this week that the Franciscan Health System in Tacoma, Wash., has begun enrolling patients for the WARFARIN (Warfarin Adverse Event Reduction for Adults Receiving Genetic Testing at Therapy Initiation) study that the company is leading in an effort to demonstrate the utility of […]
